__timestamp | Takeda Pharmaceutical Company Limited | Viking Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 382096000000 | 22223073 |
Thursday, January 1, 2015 | 345927000000 | 6966842 |
Friday, January 1, 2016 | 312303000000 | 9000499 |
Sunday, January 1, 2017 | 325441000000 | 13741186 |
Monday, January 1, 2018 | 368298000000 | 19040000 |
Tuesday, January 1, 2019 | 492381000000 | 23559000 |
Wednesday, January 1, 2020 | 455833000000 | 31931000 |
Friday, January 1, 2021 | 526087000000 | 44981000 |
Saturday, January 1, 2022 | 633325000000 | 54234000 |
Sunday, January 1, 2023 | 729924000000 | 63806000 |
Monday, January 1, 2024 | 729924000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Takeda Pharmaceutical Company Limited, a global leader, and Viking Therapeutics, Inc., a rising star, present a fascinating contrast in their R&D investments over the past decade.
From 2014 to 2023, Takeda's R&D expenses have surged by approximately 91%, reflecting its commitment to innovation. In 2023, Takeda's R&D spending reached a staggering 730 billion yen, underscoring its position as a powerhouse in the pharmaceutical industry.
Viking Therapeutics, though smaller, has shown impressive growth. From 2014 to 2023, its R&D expenses increased by nearly 187%, highlighting its aggressive pursuit of new therapies. However, Viking's spending remains a fraction of Takeda's, emphasizing the scale difference between the two.
This data offers a glimpse into the strategic priorities of these companies, with Takeda focusing on maintaining its leadership and Viking striving to carve out its niche.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited: Who Invests More in Innovation?
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.